A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $31 to $33
Pfizer & Subsidiary Sued Over Alleged Sickle Cell Drug Side Effects
Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?
Pfizer Options Spot-On: On October 31st, 97,100 Contracts Were Traded, With 3.15 Million Open Interest
On October 31st ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 97,100 options for the day, of which put options accounted for 43.15% of the total transactions, and
Zacks Investment Ideas Feature Highlights: Pfizer, Philip Morris and Tenet Healthcare
Pfizer Inc. Just Beat EPS By 161%: Here's What Analysts Think Will Happen Next